These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. Rombouts K, Marra F. Dig Dis; 2010 Dec; 28(1):229-35. PubMed ID: 20460917 [Abstract] [Full Text] [Related]
10. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE. Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618 [Abstract] [Full Text] [Related]
11. From the metabolic syndrome to NAFLD or vice versa? Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Järvinen H, Svegliati-Baroni G. Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596 [Abstract] [Full Text] [Related]
13. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression? Stefano JT, de Oliveira CP, Corrêa-Giannella ML, Soares IC, Kubrusly MS, Bellodi-Privato M, de Mello ES, de Lima VM, Carrilho FJ, Alves VA. Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736 [Abstract] [Full Text] [Related]
14. Recent advances in nonalcholic fatty liver disease. Greenfield V, Cheung O, Sanyal AJ. Curr Opin Gastroenterol; 2008 May; 24(3):320-7. PubMed ID: 18408460 [Abstract] [Full Text] [Related]
15. Activin A in nonalcoholic fatty liver disease. Yndestad A, Haukeland JW, Dahl TB, Halvorsen B, Aukrust P. Vitam Horm; 2011 May; 85():323-42. PubMed ID: 21353887 [Abstract] [Full Text] [Related]
16. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective. Lackner C. Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):223-31. PubMed ID: 21476917 [Abstract] [Full Text] [Related]
17. [Non-alcoholic fatty liver disease--new view]. Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P. Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346 [Abstract] [Full Text] [Related]
18. A human hepatocellular in vitro model to investigate steatosis. Gómez-Lechón MJ, Donato MT, Martínez-Romero A, Jiménez N, Castell JV, O'Connor JE. Chem Biol Interact; 2007 Jan 30; 165(2):106-16. PubMed ID: 17188672 [Abstract] [Full Text] [Related]
19. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Wanless IR, Shiota K. Semin Liver Dis; 2004 Feb 30; 24(1):99-106. PubMed ID: 15085490 [Abstract] [Full Text] [Related]